A 71-year-old man presented with increasing confusion after dialysis. He was admitted for progressive decline in functional status over a 1-month period including delirium, a fall, and difficulty with pain, speaking, and walking. Four years ago, he was diagnosed with stage IIIB multiple myeloma with IgAκ M-protein and corresponding κ free light chain (FLC). 3 He was treated with combination chemotherapy of cyclophosphamide, bortezomib, and dexamethasone, and he achieved partial remission. Medical history was significant for myeloma-related end-stage renal failure, hypertension, osteonecrosis of the jaw secondary to bisphosphonate, and recent onset of squamous cell carcinoma.
